https://www.selleckchem.com/pr....oducts/CI-1040-(PD18
For patients in clinical remission, a POC assay can be useful in some clinical situations to maintain or de-escalate ADA doses according to the measured trough levels. In conclusion, different assays for ADA monitoring are quite equivalent. A POC assay could be only useful for a proactive strategy for asymptomatic patients with a sub-therapeutic dose of ADA, but new therapeutic thresholds need to be identified.Toll-like receptors (TLRs) are a pivotal component of the innate immune system that seem to have a role in the pathog
Like
Comment
Share
